Michelle Luu

Michelle Luu is an experienced regulatory affairs professional with a robust background in CMC (Chemistry, Manufacturing, and Controls). Currently serving as Associate Director of Regulatory Affairs CMC at Corcept Therapeutics since June 2021, Michelle Luu provides regulatory strategies and manages complex submissions for INDs, CTAs, and NDAs. Prior roles include Sr. Analyst in Global Regulatory Affairs CMC at AbbVie and Allergan, where responsibilities encompassed managing regulatory submissions for diverse products and supporting lifecycle management of marketed products. Michelle Luu’s career began at Allergan as a Scientist, contributing to the development of ocular drug delivery systems and overseeing non-clinical studies. Michelle Luu holds a Bachelor of Science in Biology from UC Irvine.